Thyroid papillary carcinoma after alemtuzumab therapy for MS

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2014-09, Vol.261 (9), p.1828-1829
Hauptverfasser:	Ibitoye, Richard, Wilkins, Alastair
Format:	Artikel
Sprache:	eng
Schlagworte:	Alemtuzumab Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Autoimmune diseases Carcinoma - chemically induced Carcinoma - diagnosis Carcinoma, Papillary Female Health care access Humans Interferon Letter to the Editors Medicine Medicine & Public Health Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Neurology Neuroradiology Neurosciences Patients Thyroid cancer Thyroid Cancer, Papillary Thyroid diseases Thyroid Gland - drug effects Thyroid Gland - pathology Thyroid Neoplasms - chemically induced Thyroid Neoplasms - diagnosis Thyroidectomy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!